Neuromodulation has entered a new era with the adoption of accelerated protocols that can deliver a full course of treatment in just five days instead of six weeks. In late 2025, "theta-burst" stimulation is being used to target specific regions of the prefrontal cortex with high-frequency magnetic pulses, effectively "rebooting" the circuits responsible for mood regulation. These personalized...

Depression’s complexity demands more than conventional antidepressants. The treatment-resistant depression treatment market now focuses on targeting underlying neurobiological factors to improve treatment outcomes. Glutamate modulation and neuroplasticity-enhancing drugs represent a new era of rapid-response treatments. At the same time, non-pharmacological options such as transcranial...

"Key Drivers Impacting Executive Summary Treatment-Resistant Depression Market Size and Share CAGR Value The global treatment-resistant depression market size was valued at USD 1.27 billion in 2024 and is expected to reach USD 1.72 billion by 2032, at a CAGR of 3.90% during the forecast period. Business intelligence has been employed here to create...

"Executive Summary Treatment-Resistant Depression Market Size and Share Analysis Report CAGR Value The global treatment-resistant depression market size was valued at USD 1.27 billion in 2024 and is expected to reach USD 1.72 billion by 2032, at a CAGR of 3.90% during the forecast period. With the use of few steps or the combination of several steps, the...

"Executive Summary Treatment-Resistant Depression Market Size and Share Analysis Report CAGR Value The global treatment-resistant depression market size was valued at USD 1.27 billion in 2024 and is expected to reach USD 1.72 billion by 2032, at a CAGR of 3.90% during the forecast period. With the use of few steps or the combination of several steps, the...